Successful termination of atrial flutter by ibutilide during pregnancy

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 2, 2007, Pages 283-286

  Burkart, Thomas A ^a,b   Kron, Jordana ^a   Miles, William M ^a   Conti, Jamie B ^a   Gonzalez, Mario D ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b Box 100277 ^*  (United States)

Author keywords

Atrial flutter; Pharmacology; Pregnancy electrophysiology

Indexed keywords

ESMOLOL; FLECAINIDE; HEPARIN; IBUTILIDE; METOPROLOL SUCCINATE; PROPRANOLOL; SOTALOL;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC PROCEDURE; DRUG SAFETY; FEMALE; HEART ATRIUM FLUTTER; HEART RATE; HUMAN; HYPOTENSION; PHYSICAL EXAMINATION; PREGNANCY; SINGLE DRUG DOSE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SULFONAMIDES; TREATMENT OUTCOME;

EID: 33847402220     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00664.x     Document Type: Article

References (12)

1. Poppas A, Carson MP. Arrhythmias. In: Lee RV, Rosene-Montella K, Barbour LA, Garner PR, Keely E (eds.): Medical Care of the Pregnant Patient. Philadelphia, American College of Physicians, 2000, pp. 370-375.
2. Klein LL, Galan HL. Cardiac disease in pregnancy. Obstet Gynecol Clin 2004; 31(2):429-459.
3. Ellenbogen KA, Stambler BS, Wood MA, Sager PT, Wesley RC, Meissner MD, Zoble RG. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study. J Am Coll Cardiol 1996; 28:130-136.
4. Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, Vanderlugt JT, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998; 31:1414-1419.
5. Corvert Prescribing Information. Pharmacia and Upjohn Company, Kalamazoo, MI. Revised July 2002.
6. Naccarelli GV, Lee KS, Gibson JK,Vanderlugt JT. Electrophysiology and pharmacology of ibutilide. Am J Cardiol 1996; 78:12-16.
7. Murray KT. Ibutilide. Circulation 1998; 97:493-497.
8. Vanderlugt JT, Mattioni T, Denker S, Torchiana D, Ahern T, Wakefield LK, Perry KT, et al. Effecacy and safety of ibutilide fumarate for the conversion of atrial arrhythmia after cardiac surgery. Circulation 1999;100:369-375.
9. Oral H, Souza JJ, Michaud GF, Knight BP, Goyal R, Strick berger SA, Morady F. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999; 340:1849-1854.
10. Gowda RM, Khan IA, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac arrhythmias in pregnancy: Clinical and theraputic considerations. Int J Cardiol 2003; 88:129-133.
11. Danielsson BR, Sköd A, Azarbayjani F. Class III antiarrhythmics and phenytoin: Teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage. Curr Pharm Des 2001; 7:787-802.
12. Marks TA, Terry RD. Developmental toxicity of ibutilide fumarate in rats after oral administration. Teratology 1996; 54(3):157-164.